Kalff V, Kelly M J, McGrath B
Med J Aust. 1984 Sep 29;141(7):457-9. doi: 10.5694/j.1326-5377.1984.tb132867.x.
A new adrenomedullary scintigraphic imaging agent, iodine-131-labelled metaiodobenzylguanidine (MIBG), was used to localize a recurrent phaeochromocytoma in a 27-year-old man in whom the site of tumour could not be determined by any other means. MIBG scintigraphy is easy to perform and is highly specific for functioning aberrant adrenomedullary tissue. It complements other methods for localization of phaeochromocytoma and, under some circumstances, it may become the initial imaging procedure of choice in the screening of patients in whom the biochemical or clinical evidence suggests the presence of such tumours.
一种新的肾上腺髓质闪烁显像剂，碘-131标记的间碘苄胍（MIBG），被用于在一名27岁男性中定位复发性嗜铬细胞瘤，该患者肿瘤的位置无法通过任何其他方法确定。MIBG闪烁显像易于操作，对功能性异常肾上腺髓质组织具有高度特异性。它补充了嗜铬细胞瘤定位的其他方法，在某些情况下，它可能成为对生化或临床证据提示存在此类肿瘤的患者进行筛查时首选的初始成像检查。
